Trial intelligence / Profile preview

Sevoflurane, Desflurane, and TIVA in Pituitary Surgery

NCT02709863Unknown

Sponsor
Istanbul University
Start
Oct 2015
Primary completion
Feb 2017
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised trial of sevoflurane, desflurane and propofol injection (veterinary) in pituitary adenoma, sponsored by Istanbul University. Primary endpoint: Forced Expiratory Volume in 1st Second % predicted. Status: unknown.

02

Drugs

sevofluranedesfluranepropofol injection (veterinary)
03

Conditions

pituitary adenoma

Beyond the preview

Go deeper on NCT02709863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02709863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call